BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8206075)

  • 1. Consolidation therapy in patients with advanced ovarian cancer.
    Vermorken JB
    Eur J Gynaecol Oncol; 1994; 15(1):7-13. PubMed ID: 8206075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy of ovarian cancer: state of the art].
    Paulus A; Gennigens C; Fillet G; Loly C; Sautois B
    Rev Med Liege; 2007 Sep; 62(9):539-47. PubMed ID: 17966789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer.
    Aziz Z; Zahid M; Ud Din Ahmed Z; Arshad T
    Aust N Z J Med; 1998 Jun; 28(3):403-9. PubMed ID: 9673759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary treatment of epithelial ovarian malignancies.
    McGuire WP
    Cancer; 1993 Feb; 71(4 Suppl):1541-50. PubMed ID: 8431892
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
    Trimbos JB; Parmar M; Vergote I; Guthrie D; Bolis G; Colombo N; Vermorken JB; Torri V; Mangioni C; Pecorelli S; Lissoni A; Swart AM; ;
    J Natl Cancer Inst; 2003 Jan; 95(2):105-12. PubMed ID: 12529343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
    Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
    Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: a retrospective case-control study.
    Vrscaj MU; Rakar S
    Eur J Gynaecol Oncol; 2002; 23(5):405-10. PubMed ID: 12440812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytoprotective effect of Amifostine in the combined chemotherapy of advanced ovarian carcinoma].
    Nagy P; Kádasi L
    Orv Hetil; 2000 Sep; 141(37):2027-30. PubMed ID: 11037611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line therapy for ovarian carcinoma: what's next?
    Thigpen T
    Cancer Invest; 2004; 22 Suppl 2():21-8. PubMed ID: 15573742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients.
    Rocconi RP; Straughn JM; Leath CA; Kilgore LC; Huh WK; Barnes MN; Partridge EE; Alvarez RD
    Oncologist; 2006 Apr; 11(4):336-41. PubMed ID: 16614229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The impact of the pathologist on the treatment of epithelial ovarial cancer].
    Zivanovic O; Braun M; Park TW; Kuhn W
    Verh Dtsch Ges Pathol; 2005; 89():101-10. PubMed ID: 18035679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remission.
    Dufour P; Bergerat JP; Barats JC; Giron C; Duclos B; Dellenbach P; Ritter J; Renaud R; Audhuy B; Oberling F
    Cancer; 1994 Apr; 73(7):1865-9. PubMed ID: 8137212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraoperative chemotherapy with mitoxantrone and cisplatin after extensive debulking in the treatment of stage III and IV epithelial neoplasms of the ovaries].
    Griggio L; Tasinato R
    Tumori; 1999; 85(3 Suppl 1):S49-51. PubMed ID: 10542889
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic surgical staging: stage I ovarian cancer.
    Piver MS
    J Clin Oncol; 1997 Feb; 15(2):864-5. PubMed ID: 9053518
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy and radiation therapy in the treatment of ovarian carcinoma of common epithelial origin.
    Wharton JT; Edwards CL; Stringer CA; Delclos L
    Clin Obstet Gynecol; 1985 Dec; 28(4):806-15. PubMed ID: 4075632
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvant chemotherapy in patients operated on for early ovarian carcinoma].
    Trimbos JB; van der Burg ME
    Ned Tijdschr Geneeskd; 2004 May; 148(18):874-8. PubMed ID: 15152388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of care for women with ovarian cancer in the United States.
    Muñoz KA; Harlan LC; Trimble EL
    J Clin Oncol; 1997 Nov; 15(11):3408-15. PubMed ID: 9363873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of medroxyprogesterone acetate against advanced ovarian carcinoma: a pilot study.
    Niwa K; Onogi K; Wu Y; Mori H; Harrigan RC; Tamaya T
    Eur J Gynaecol Oncol; 2008; 29(3):252-5. PubMed ID: 18592789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.